Previous 10 | Next 10 |
home / stock / crl / crl articles
Charles River Laboratories International Inc (NYSE:CRL) reported fourth-quarter 2023 revenue of $1.01 billion, a decrease of 7.9% Y/Y, beating...
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and...
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. Shares of Charles River Laboratories International, I...
Disclosed in a recent SEC filing on January 31, Foster, Chairman at Charles River (NYSE:CRL), made a noteworthy transaction involving the exercise ...
SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Dollar General Corporation Johnson Fistel, LLP is investigating potential claims on behalf of Doll...
SAN DIEGO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- FedEx Corporation (NYSE:FDX) Johnson Fistel, LLP is investigating potential claims on behalf of Fe...
Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make...
Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating ...
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Near Intelligence, Inc. (NASDAQ: NIR) g...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract...
2024-06-18 18:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector productio...